Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,646.60 -3.91 -0.24%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Berlin
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Laboratorios Farmaceuticos Rovi SA

+ Add to Watchlist

41L:GR

6.574 EUR 0.036 0.54%

As of 02:32:29 ET on 05/24/2013.

Company Profile for Laboratorios Farmaceuticos Rovi SA (41L)

Laboratorios Farmaceuticos Rovi SA is a specialty pharmaceutical company. The Company researches, develops, manufactures, and markets small molecule and specialty biologic drugs. Rovi's services include contract manufacturing of aseptic filling and packaging of small-volume parenterals in prefilled syringes and vials and provides temperature-controlled storage facilities.

Contact Information

Laboratorios Farmaceuticos Rovi SA

Julian Camarillo 35
Madrid, 28037
Spain
Phone: 34-91-375-62-30
Fax: 34-91-304-78-81

Key Executives for Laboratorios Farmaceuticos Rovi SA (41L)

Juan Lopez-Belmonte LopezChairman/Co-CEOJuan Lopez-Belmonte EncinaCo-CEO/General Director
Javier Lopez-Belmonte EncinaChief Financial OfficerFrancisco Javier Angulo GarciaDir:Human Resources
Fernando Martinez MoralesDir:CommercialJose Eduardo Gonzalez MartinezDir:Institutional Relations
Ivan Lopez-Belmonte EncinaDir:Corporate DevelopmentJavier Martinez GonzalezDir:Clinic Development
Pablo Carretero TrilloDir:Hospital Network

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil